Loading...
Palivizumab epitope–displaying virus-like particles protect rodents from RSV challenge
Respiratory syncytial virus (RSV) is the most common cause of serious viral bronchiolitis in infants, young children, and the elderly. Currently, there is not an FDA-approved vaccine available for RSV, though the mAb palivizumab is licensed to reduce the incidence of RSV disease in premature or at-r...
Na minha lista:
| Udgivet i: | J Clin Invest |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Clinical Investigation
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4409022/ https://ncbi.nlm.nih.gov/pubmed/25751145 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI78450 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|